Advanced search    

Search: authors:"Heinz H. Coenen"

5 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines

London , London , UK 2 National Institute of Mental Health , Bethesda , USA 3 Research Centre Jülich , Jülich , Germany 4 Antony D. Gee 5 Yours sincerely , Heinz H. Coenen and Antony D. Gee 6 Ludwig

Effects of Magnetic Fields of up to 9.4 T on Resolution and Contrast of PET Images as Measured with an MR-BrainPET

0 Elena Rota Kops 0 Syed M. Qaim Heinz H. Coenen Hidehiro Iida Karl Herholz, University of Manchester, United Kingdom 0 Institute of Neuroscience and Medicine, INM-4: Medical Imaging Physics

pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?

Background The present study was conducted to analyze the value of ([18F] fluoromisonidazole (FMISO) and [18F]-2-fluoro-2'-deoxyglucose (FDG) PET as well as color pixel density (CPD) and tumor perfusion (TP) assessed by color duplex sonography (CDS) for determination of therapeutic relevant hypoxia. As a standard for measuring tissue oxygenation in human tumors, the invasive...

[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study

Background Experimental and clinical evidence suggest that hypoxia in solid tumours reduces their sensitivity to conventional treatment modalities modulating response to ionizing radiation or chemotherapeutic agents. The aim of the present study was to show the feasibility of determining radiotherapeutically relevant hypoxia and early tumour response by ([18F] Fluoromisonidazole...

RADIOLOGY

OBJECTIVE: Cerebral radiation necrosis occurs after radiotherapy in brain tumors. However, its etiology still remains unclear and the treatment has not been established. Recently, it has been reported that bevacizumab(BEV)is a therapeutic option for cerebral radiation necrosis. In this study, we investigate the changes of MRI after BEV in patients with malignant glioma followed...